Ageing, late-onset asthma and the beta-adrenoceptor

Area of Science:

• Geriatric Medicine
• Pulmonology
• Pharmacology

Background:

• Late-onset asthma is a significant clinical issue in the elderly population.
• Similarities exist in beta 2-adrenoceptor function between young asthmatics and elderly non-asthmatics.
• The concept of 'aging' beta 2-adrenoceptors is proposed as a factor in late-onset asthma.

Purpose of the Study:

• To explore the role of aging beta 2-adrenoceptors in the development of late-onset asthma.
• To address unresolved questions regarding the peripheral mononuclear cell model and receptor tachyphylaxis.

Main Methods:

• Review of existing evidence on beta 2-adrenoceptor function in asthma and aging.
• Analysis of receptor and post-receptor abnormalities.
• Consideration of in vitro models and their limitations.

Main Results:

• Evidence suggests a potential link between 'aging' beta 2-adrenoceptors and late-onset asthma.
• The validity of peripheral mononuclear cell models requires further investigation.
• Receptor tachyphylaxis to beta-adrenoceptor agonists remains an area of uncertainty.

Conclusions:

• The 'aging' beta 2-adrenoceptor is a plausible, though not fully confirmed, contributor to late-onset asthma.
• Future research should prioritize in vivo airway receptor studies.
• Investigating beta 2-adrenoceptor pathways beyond smooth muscle contraction is recommended.